New mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immunotherapy
摘要:
The present invention relates to engineered immune cells expressing new mesothelin (MLSN) specific chimeric antigen receptors (anti-mesothelin CAR) and their use in the treatment of solid tumors, particularly suited for allogeneic cell immunotherapy.
信息查询
0/0